| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.11 | 0.6 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.6 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | 0.093 | 0.6 |